Literature DB >> 8138808

Reversal of impaired oxidative phosphorylation and calcium overloading in the in vitro cardiac mitochondria of CHF-146 dystrophic hamsters with hereditary muscular dystrophy.

S K Bhattacharya1, P L Johnson, J H Thakar.   

Abstract

Membrane-mediated excessive intracellular calcium accumulation (EICA), and diminished cellular energy charge are invariably present in the myocardium of CHF-146 strain dystrophic hamsters (DH) with hereditary muscular dystrophy (HMD) and hypertrophic cardiomyopathy (HC). Therefore, we investigated respiratory dysfunctions and Ca2+ overloading in the isolated cardiac mitochondria from young and old DH, and whether these abnormalities can be reversed by controlling EICA in the in vitro mitochondria upon chelating excessive Ca2+ from the isolation medium with EDTA. Age- and sex-matched CHF-148 strain albino normal hamsters (NH) served as the disease controls. As an index of membrane-mediated EICA and chronic cellular degeneration, Ca and Mg concentrations were quantitated in the ventricular myocardium and in the cardiac mitochondria harvested in two different isolation media. Mitochondria from young and old DH, isolated in the absence of 10 mM EDTA (B0 medium), revealed poor coupling of oxidative phosphorylation, diminished stimulated oxygen consumption rate, and lower respiratory control and ADP/O ratios, than those seen in NH. However, incorporation of 10 mM EDTA in the isolation medium (B medium) restored the mitochondrial functions and reduced massive Ca(2+)-overloading in the dystrophic organelles. Ca concentration in the in vitro mitochondria from DH was significantly higher than in NH, irrespective of the composition of the isolation medium and age of the hamsters. Furthermore, the dystrophic organelles isolated in B medium had a much lower Ca concentration, and markedly improved oxidative phosphorylation as seen in the cardiac mitochondria from NH, compared to those prepared using B0 medium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138808     DOI: 10.1016/0022-510x(93)90271-y

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Mitochondria-targeted cardioprotection in aldosteronism.

Authors:  Atta U Shahbaz; German Kamalov; Wenyuan Zhao; Tieqiang Zhao; Patti L Johnson; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2011-01       Impact factor: 3.105

Review 2.  Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.

Authors:  Malay S Gandhi; German Kamalov; Atta U Shahbaz; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.

Authors:  German Kamalov; Robert A Ahokas; Wenyuan Zhao; Atta U Shahbaz; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-13       Impact factor: 4.733

4.  Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

Authors:  German Kamalov; Prajwal A Deshmukh; Narina Y Baburyan; Malay S Gandhi; Patti L Johnson; Robert A Ahokas; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2009-05       Impact factor: 3.105

5.  Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.

Authors:  Emma Rybalka; Cara A Timpani; Matthew B Cooke; Andrew D Williams; Alan Hayes
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 6.  Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?

Authors:  Spandan Kalra; Federica Montanaro; Chris Denning
Journal:  J Neuromuscul Dis       Date:  2016-08-30

7.  Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.

Authors:  Cara A Timpani; Craig A Goodman; Christos G Stathis; Jason D White; Kamel Mamchaoui; Gillian Butler-Browne; Nuri Gueven; Alan Hayes; Emma Rybalka
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.